SUSQUEHANNA INTERNATIONAL GROUP, LLP - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 17 filers reported holding CLEVELAND BIOLABS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q2 2021$131,000
+1537.5%
23,995
+72.4%
0.00%
Q4 2019$8,000
-61.9%
13,922
-33.8%
0.00%
Q3 2019$21,000
+40.0%
21,043
+37.8%
0.00%
Q4 2018$15,000
-72.7%
15,268
-44.1%
0.00%
Q3 2018$55,000
-14.1%
27,310
+5.1%
0.00%
Q2 2018$64,000
+77.8%
25,982
+116.8%
0.00%
Q1 2018$36,000
+12.5%
11,987
-46.0%
0.00%
Q4 2016$32,00022,2160.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q1 2020
NameSharesValueWeighting ↓
THOMPSON DAVIS & CO., INC. 1,800$8,0000.01%
VANGUARD GROUP INC 4,644,077$162,991,0000.01%
LADENBURG THALMANN FINANCIAL SERVICES INC. 38,888$158,0000.00%
Winfield Associates, Inc. 786$3,0000.00%
Virtu KCG Holdings LLC 11,022$48,0000.00%
UBS Group AG 182$00.00%
BLACKROCK ADVISORS LLC 2,800$12,0000.00%
US BANCORP \DE\ 100$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 37$00.00%
BANK OF AMERICA CORP /DE/ 150$1,0000.00%
View complete list of CLEVELAND BIOLABS INC shareholders